Gene Link

Gene Link is a long-established, private provider of custom oligonucleotides and genetic analysis reagents, operating primarily as a high-touch service and product company for the research and diagnostic development markets. Its core value proposition is superior quality and reliability, particularly for complex modifications, long sequences (up to 250 bases), and specialized applications like non-radioactive genotyping for triplet repeat disorders. While not a therapeutic developer, the company serves as a critical enabler for academic, biotech, and pharmaceutical research through its synthesis and diagnostic tool offerings.

Proprietary oligonucleotide synthesis platform with real-time coupling monitoring and post-synthesis PAGE analysis. Capabilities include synthesis of long oligos (up to 250 bases), a wide array of chemical modifications (Morpholino, phosphorothioate, fluorescent dyes), and non-radioactive detection methods for genotyping.

Gene Link competes in a fragmented but top-heavy market. It differentiates itself from mass-market leaders like Integrated DNA Technologies (IDT) and Thermo Fisher Scientific through a high-touch, quality-focused service model for complex and long oligos. It also competes with other specialty synthesis shops and diagnostic reagent providers.